20 Stocks Moving in Monday's Pre-Market Session

Gainers

• Nektar Therapeutics NKTR shares rose 8.5% to $21.75 in pre-market trading. Nektar Therapeutics presented data from first-in-human Phase 1a study on Novel T regulatory cell stimulator, NKTR-358 at the ACR 2019.
• Can-Fite BioPharma Ltd. CANF rose 8% to $2.57 in pre-market trading after the company was granted US Patent for piclidenoson in the treatment of osteoarthritis.
• Medical Properties Trust, Inc. MPW rose 8% to $21.54 in pre-market trading.
• Pier 1 Imports, Inc. PIR rose 6.4% to $7.16 in pre-market trading after dropping 7.81% on Friday.
• Amicus Therapeutics, Inc. FOLD shares rose 6.2% to $9.49 in pre-market trading as the company reported upbeat earnings for its third quarter and raised the lower end of its Galafold revenue guidance.
• SunPower Corporation SPWR shares rose 5.6% to $8.84 in pre-market trading after the company announced plans to split into two independent publicly-traded companies.
• Evolent Health, Inc. EVH rose 5.6% to $10.69 in pre-market trading after climbing 8.47% on Friday.
• MyoKardia, Inc. MYOK rose 4.7% to $62.84 in pre-market trading.
• Internet Gold - Golden Lines Ltd. IGLD rose 4% to $12.74 in pre-market trading after falling 12.57% on Friday.
• Digital Turbine, Inc. APPS rose 4% to $7.35 in pre-market trading.
• Teva Pharmaceutical Industries Limited TEVA shares rose 3.8% to $9.65 in pre-market trading after gaining 9.80% on Friday.
• PTC Therapeutics, Inc. PTCT rose 3.6% to $42.66 in pre-market trading. PTC Therapeutics said Risdiplam Pivotal SUNFISH study demonstrated statistically significant improvement for patients with Type 2/3 spinal muscular atrophy.
• Inovalon Holdings, Inc. INOV shares rose 3.2% to $17.20 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Check out these big penny stock gainers and losers

Losers

• NextCure, Inc. NXTC shares fell 55.4% to $37.00 in pre-market trading after the company announced updated clinical data from NC318 Phase 1/2 clinical trial presented at the SITC 2019.
• Foamix Pharmaceuticals Ltd. FOMX fell 10.1% to $3.90 in pre-market trading. Foamix Pharmaceuticals and Menlo Therapeutics Inc. MNLO reported a merger agreement to create a combined biopharmaceutical company.
• Tupperware Brands Corporation TUP fell 6.3% to $8.75 after the company reported plans to suspend quarterly dividend.
• Lumentum Holdings Inc. LITE fell 3.8% to $64.00 in pre-market trading.
• United States Steel Corporation X fell 3.4% to $13.11 in pre-market trading.
• Constellation Pharmaceuticals, Inc. CNST fell 3.4% to $29.87.
• Rio Tinto Group RIO fell 3.3% to $52.35 in the pre-market trading session.